Table of Contents

company-logo

InhaleRx Limited engages in the developing and commercializing of medical drug delivery systems in Australia. It also develops inhaled drug formulations. Its solutions include Medihale inhaler, a sealed pod inhaler for use with inhaled formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Sydney, Australia.

InhaleRx Dividend Announcement

• InhaleRx does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on InhaleRx dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

InhaleRx Dividend History

InhaleRx Dividend Yield

InhaleRx current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing InhaleRx stock? Use our calculator to estimate your expected dividend yield:

InhaleRx Financial Ratios

P/E ratio-9.66
PEG ratio0.10
P/B ratio-142.36
ROE-196.76%
Payout ratio0.00%
Current ratio0.92
Quick ratio0.92
Cash Ratio0.53

InhaleRx Dividend FAQ

Does InhaleRx stock pay dividends?
InhaleRx does not currently pay dividends to its shareholders.
Has InhaleRx ever paid a dividend?
No, InhaleRx has no a history of paying dividends to its shareholders. InhaleRx is not known for its dividend payments.
Why doesn't InhaleRx pay dividends?
There are several potential reasons why InhaleRx would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will InhaleRx ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While InhaleRx has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is InhaleRx a dividend aristocrat?
InhaleRx is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is InhaleRx a dividend king?
InhaleRx is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is InhaleRx a dividend stock?
No, InhaleRx is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy InhaleRx stocks?
To buy InhaleRx you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy InhaleRx stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.